|
Hi Taylor
- As nervous as I am for what's going on right now, I'm also worried
about next fall and the winter. It seems like the vaccine won't be
here for a while. Any information that might calm my nerves about
that? - Melinda
Hi Melinda - Those are good concerns that I definitely share.
I've got my family hunkering down to stay safe now, but it's also
important that our country doesn't survive the first wave of this
virus only to get hit harder by a second round.
A vaccine will have a huge global impact, both for the obvious health
reasons and also for the markets. A few things I've learned that will
help us stay informed. |
1. Vaccines
don't develop overnight. Because we're so used to antibiotics
and other medications that are just a quick prescription away,
it's hard for people to think about the science behind identifying
a new strain of virus and then creating a medicine that will kill
that foreign agent without hurting the infected person. Historically,
reliable vaccines have taken at least five and as many as 15 years
to make. That said, the Zika virus vaccine went to clinical trials
after only seven months. With so many companies working to find
a solution, I feel confident a viable treatment will arrive sooner
than later. It might not feel soon enough, but we have to remember
what a difficult task this is for our medical community.
2. The country of origin makes a difference. Something we
have to remember is that wherever the vaccine is developed might
see the most accessibility at first. Once the medicine exists,
it still has to be manufactured. If it gets successfully created
in Germany, more Germans than Americans will likely have access
in the early going. This is mostly to say - don't run to the mall
the day you hear a vaccine in Norway has passed clinical trials.
We need to keep our guard up until it's clear the U.S. has a system
for treatment in place. There will also be a cost associated with
acquiring vast amounts of medicine, which will be both good and
trying for different economic sectors.
3. The CEPI will help. The Coalition for Epidemic Preparedness
Innovations is actively funding medical research institutions
in the U.S. and other countries, helping to make sure a vaccine
is created and then produced on a massive scale. The CEPI wasn't
founded until 2017, so having this institution around at this
moment in history will be hugely beneficial.
|
My advice would
be to stay patient instead of feeling scared. These are difficult
times, but those of us who have our health should count our blessings
while we wait for the next step in combating this virus. Stay safe!
© Taylor Kovar
April 6, 2020
More "Go Far With Kovar" |
Legal Disclaimer:
Information presented is for educational purposes only and is not
an offer or solicitation for the sale or purchase of any specific
securities, investments, or investment strategies. Investments involve
risk and, unless otherwise stated, are not guaranteed. Be sure to
first consult with a qualified financial adviser and/or tax professional
before implementing any strategy discussed herein. To submit a question
to be answered in this column, please send it via email to Question@GoFarWithKovar.com,
or via USPS to Taylor Kovar, 415 S 1st St, Suite 300, Lufkin, TX 75901.
|
|
|